Gilead Sciences, Inc.GILDNASDAQ
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank21
3Y CAGR-2.9%
5Y CAGR-8.8%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-2.9%/yr
vs -1.8%/yr prior
5Y CAGR
-8.8%/yr
Recent acceleration
Acceleration
-1.1pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.09 | -21.3% |
| 2024 | 1.38 | +26.3% |
| 2023 | 1.09 | -7.9% |
| 2022 | 1.19 | -6.2% |
| 2021 | 1.27 | -26.6% |
| 2020 | 1.73 | +58.0% |
| 2019 | 1.09 | -14.5% |
| 2018 | 1.28 | -22.1% |
| 2017 | 1.64 | +17.6% |
| 2016 | 1.39 | - |